Iovance Biotherapeutics Inc (NASDAQ:IOVA)
| 24.78 Delayed Data As of Jun 18 |  +0.16 / +0.65%Today’s Change | 15.88 Today|||52-Week Range 54.21 | -46.59% Year-to-Date |
Latest IOVA News | Press Releases
| Should You Buy This Cathie Wood Biotech Stock? Jun 17 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 24.62 |
| Today’s open | 23.71 |
| Day’s range | 24.10 - 25.12 |
| Volume | 153,086 |
| Average volume (3 months) | 3,224,901 |
| Market cap | $3.7B |
Data as of 3:59pm ET, 06/18/2021
Growth & Valuation
| Earnings growth (last year) | -18.13% |
| Earnings growth (this year) | -10.53% |
| Earnings growth (next 5 years) | -19.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 5.44 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ALLOAllogene Therapeutic... | -0.19 | -0.77% |
| KODKodiak Sciences Inc | +0.08 | +0.10% |
| ---- | ||
| NTLAIntellia Therapeutic... | -0.49 | -0.64% |
Data as of 4:39pm ET, 06/18/2021
Financials
| Next reporting date | August 4, 2021 |
| EPS forecast (this quarter) | -$0.51 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$259.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Carlos, California |
Forecasts
